Walking a Fine Line: Safe and Effective Management of Type 2 Diabetes in Older Adults

Thursday, April 14, 2022, 3:00 PM - Thursday, April 13, 2023, 11:59 PM

AMA PRA Category 1 Credits™ (1.00 hours), AMA PRA Category 1 Credits™ Designated (1.00 hours)

Expert-authored commentaries providing expert insight into the management of type 2 diabetes in older adults including individualization of treatment goals, use of fixed-ratio combination insulin and GLP-1 RA, and management considerations in the long-term care facility setting.

The goal of this activity is to improve the knowledge and competence of geriatricians, gerontological nurse practitioners, consultant and senior care pharmacists, and other healthcare professionals regarding the management of older adults with diabetes, including those in a long-term care setting.

There are no fees for participating in and receiving CME credit for this online activity.

Click register now, to access this activity.

1. Identify patient specific-factors that should be considered when determining individualized glycemic goals for older adults with T2D;
2. Describe the efficacy and safety from clinical study results to support the use of FRC basal insulin and GLP-1 RAs in appropriate patients;
3. Integrate FRC basal insulin and GLP-1 RAs into the care of appropriate patients according to guideline recommendations and patient factors/preferences;
4. Detail important patient and drug considerations that can help ensure safe and effective T2D pharmacotherapy in older patients residing in LTCFs.

PHYSICIAN CONTINUING EDUCATION (ACCME/AMA)
The University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Cincinnati designates this webcast activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.

The University of Cincinnati and Clinical Care Options are accredited by the ACCME to provide continuing medical education for physicians, and have collaborated to design and execute this activity.

For accreditation purposes, the University of Cincinnati is responsible for certification and documentation of attendance for activity.

**The American Academy of Physician Assistants accept certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

NURSING CONTINUING EDUCATION (GAPNA)
This educational activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ), the Gerontological Advanced Practice Nurses Association (GAPNA), and Clinical Care Options.   
     
Anthony J. Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, Provider Number CEP5387.
1.0 contact hour (which includes 1 hour of pharmacology credit) will be earned by learners who successfully complete this nursing continuing professional development activity.

You must participate in at least 90% of this activity and complete the evaluation form to receive nursing continuing professional development credit

PHARMACY CONTINUING EDUCATION (ASCP)
The American Society of Consultant Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ASCP designates this continuing education activity for 1.0 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number: 0203-9999-22-003-L01-P

Type of Activity: Application

You must participate in this activity in its entirety and complete the evaluation form to receive CPE credit. Partial credit will not be granted. The course should be posted to CPE Monitor within 60 days of evaluation completion.

Provided by the University of Cincinnati, in collaboration with ASCP and GAPNA.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer Statement
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by healthcare professionals without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Disclosure of Relationships with Ineligible Entities

In accordance with the ACCME Standards for Integrity and Independence and the University of Cincinnati policy, all faculty, planning committee members, and other individuals, who are in a position to control content, are required to disclose all relationships with ineligible companies (commercial interest) within the last 24-months. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence. The ACCME requires us to disqualify individuals who refuse to provide this information from involvement in the planning and implementation of accredited continuing education.

Faculty Disclosures
The faculty have no relevant conflicts of interest to report.

Derek LeRoith, MD, PhD
Professor
Physician
Division of Endocrinology
Department of Medicine
Mount Sinai School of Medicine
Mount Sinai Hospital
New York, New York

Jane Jeffrie Seley, DNP, MPH, MSN, GNP, BC-ADM, CDCES
Assistant Professor of Medicine
Diabetes Nurse Practitioner
Division of Endocrinology, Diabetes, and Metabolism
Weill Cornell Medicine
New York, New York

Haley M. Phillippe, PharmD, BCPS, BCGP, FASCPAssociate Clinical Professor
Pharmacy Practice
Auburn University Harrison School of Pharmacy
Ambulatory Care Clinical Pharmacist
Family Medicine, Huntsville Campus
University of Alabama at Birmingham School of Medicine
Huntsville, Alabama

Planning Committee Members

 The University of Cincinnati; American Society of Consultant Pharmacists; Anthony J. Jannetti, Inc. (AJJ), the Gerontological Advanced Practice Nurses Association (GAPNA); Clinical Care Options, LLC; and the peer/content reviewers for this activity have no relevant conflict of interest to report.

Mitigation of Relevant Financial Relationships

The University of Cincinnati adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (commercial interests) over the last 24-months. All relevant relationships have been mitigated prior to the commencement of the activity.

Information regarding the new updated ACCME Standards for Integrity and Independence in Accredited Continuing Education can be found on the ACCME website.

This educational activity is supported by an educational grant from Sanofi US.